Cat: IPD-X13019

Recombinant Rat VEGF-D Protein(HEK293), N-hFc

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • Gene name

    VEGF-D

  • 简介

    VEGF-D, a growth factor, stimulates proliferation, migration, and vessel permeability. It is crucial for vascular development and maintenance of lymphatic endothelium. VEGF-D binds and activates VEGFR-3, initiating essential signaling pathways. Structurally, it forms a non-covalent homodimer, playing an intricate role in vascular processes. VEGF-D Protein, Rat (HEK293, Fc) is the recombinant rat-derived VEGF-D protein, expressed by HEK293 , with N-hFc labeled tag.

  • Application

    SPRMSTBLIITCELISACELL ASSAYDRUG SCREENING

  • Biological Activity

    Measured by its binding ability in a functional ELISA. Immobilized recombinant Rat VEGF-DD at 10 μg/mL (100 μL/well) can bind biotinylated Mouse VEGFR-3. The ED50 for this effect is 312.9 ng/mL. Measured by its binding ability in a functional ELISA. Immobilized recombinant Rat VEGF-DD at 10 μg/mL (100 μL/well) can bind biotinylated Mouse VEGFR-3 .The ED50 for this effect is 312.9 ng/mL.

  • Alternative Names

    Vascular endothelial growth factor D; VEGF-D; FIGF

  • Species

    Rat

  • Source

    HEK293

  • Tag

    N-hFc

  • Purity

    Greater than 95% as determined by reducing SDS-PAGE.

  • Uniprot

    O35251

  • Expression Region

    F94-R210

  • Protein Length

    Partial

  • Molecular Weight

    52 kDa

  • Endotoxin

    < 1.0 EU per μg protein as determined by the LAL method.

  • Form

    Freeze-dried powder

  • Buffer formulation

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • Reconstitution

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • Customization

    Site-directed mutagenesis Custom tag design Custom buffer formulation Custom full-length protein production

  • Stability Test

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • Storage & Shelf Life

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • Shipping

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

Vascular endothelial growth factor D (VEGF-D) is a member of the VEGF family, which plays a critical role in lymphangiogenesis and angiogenesis, processes essential for normal physiological functions as well as in pathological conditions such as cancer, lymphedema, and inflammatory diseases. Research on VEGF-D has gained momentum due to its significant role in the formation of lymphatic vessels and its potential implications in tumor metastasis and lymphatic system disorders. Unlike other members of the VEGF family, VEGF-D specifically acts on lymphatic endothelial cells, promoting their proliferation and migration. Variations in VEGF-D expression have been associated with various diseases, making it a potential biomarker for disease progression. Additionally, therapeutic interventions targeting VEGF-D may provide novel strategies for treating conditions linked to its dysregulation. The recombinant protein version of VEGF-D has been studied as a tool for both basic research and potential therapeutic applications, exploring its function in promoting lymphatic vessel growth in animal models and assessing its safety and efficacy in clinical settings. As our understanding of VEGF-D's mechanistic roles deepens, it opens avenues for innovative treatments in cancer therapy and regenerative medicine, harnessing its properties to enhance tissue repair and modulate immune responses. This growing body of research emphasizes the importance of VEGF-D in both health and disease, highlighting its potential as a target for future therapeutic development and clinical applications.

E-mail

sales@ipodix.com

Sales

+1 2092920560


Contact us via WhatsApp

IPODIX Biotech Inc

2108 N ST, STE N
Sacramento, CA 95816, USA

For Product Information and Orders

sales@ipodix.com

For Business Collaboration

sales@ipodix.com

For CRO Services

sales@ipodix.com

For Technical Support

sales@ipodix.com
  • 50000+

    Recombinant Proteins

  • 100+

    Researchers

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US